2m 2m 2m 2m 2m 2m 2m
MEIRAGTX (MGTX)
NASDAQ
$11.80-$0.010 (-0.08%)
Price as of Jun 23, 2026 4:10 PM EDT- $508.4MMarket Cap
- 81.93%1-Year Change
- BiotechnologyIndustry
MEIRAGTX (MGTX)
$11.80-$0.010 (-0.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.4M -80.77% | 33.3M N/A | N/A N/A | 15.9M -57.77% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 6.4M -80.77% | 33.3M N/A | 0 -100.00% | 15.9M -57.77% | |
Sales and Marketing Expense | 4.8M -79.64% | 23.8M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -129.6M +8.48% | -119.5M +15.13% | -103.8M +21.07% | -85.7M +27.70% | |
Depreciation and Amortization Expense | 12.5M -2.23% | 12.8M -6.57% | 13.7M +57.40% | 8.7M +10.80% | |
Total Operating Expenses | 187.4M -5.13% | 197.5M +30.72% | 151.1M +14.22% | 132.3M +19.28% | |
Operating Profit | -106.0M -35.47% | -164.2M +19.81% | -137.1M +17.80% | -116.4M +58.97% | |
Interest Income | 1.8M -56.14% | 4.1M +82.44% | 2.3M +192.41% | 777,000 +266.51% | |
Interest Expense | -12.2M -8.10% | -13.3M +0.20% | -13.2M +167.79% | -4.9M +1,617.36% | |
Interest Income and Expense and Net | -10.4M +13.72% | -9.1M -16.82% | -11.0M +163.20% | -4.2M +5,385.53% | |
Total Nonoperating Income and Expense | 12.2M -8.10% | 13.3M +0.20% | 13.2M +167.79% | 4.9M +1,617.36% | |
Income before Taxes | -114.2M -22.73% | -147.8M +75.89% | -84.0M -35.17% | -129.6M +62.91% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -114.2M -22.73% | -147.8M +75.89% | -84.0M -35.17% | -129.6M +62.91% | |
Net Income from Continuing Operations Applicable to Common | -114.2M -22.73% | -147.8M +75.89% | -84.0M -35.17% | -129.6M +62.91% | |
Basic EPS and Net Income | -1.42 -33.02% | -2.12 +42.28% | -1.49 -48.08% | -2.87 +59.44% | |
Diluted EPS and Net Income | -1.42 -33.02% | -2.12 +42.28% | -1.49 -48.08% | -2.87 +59.44% | |
Basic Weighted Average Shares | 80.4M +15.19% | 69.8M +23.61% | 56.5M +25.03% | 45.2M +2.35% | |
Diluted Weighted Average Shares | 80.4M +15.19% | 69.8M +23.61% | 56.5M +25.03% | 45.2M +2.35% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 65.9M -36.40% | 103.7M -20.00% | 129.6M +12.16% | 115.5M -16.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 65.9M -36.40% | 103.7M -20.00% | 129.6M +12.16% | 115.5M -16.11% | |
Total Current Assets | 91.8M -25.71% | 123.5M -22.62% | 159.6M +3.42% | 154.3M -15.77% | |
Accumulated Depreciation | 52.6M +24.41% | 42.3M +26.94% | 33.3M +63.41% | 20.4M +40.85% | |
Property and Plant and Equipment and Net | 105.5M +2.51% | 102.9M -11.23% | 115.9M +6.07% | 109.3M +44.04% | |
Total Long-Term Assets | 1.1M +14.47% | 1.0M -47.73% | 1.9M +36.73% | 1.4M -0.14% | |
Total Assets | 244.4M -9.39% | 269.8M -17.44% | 326.7M +2.67% | 318.2M -0.60% | |
Income Taxes Payable | N/A N/A | N/A N/A | 186,000 0.00% | 186,000 -5.10% | |
Total Short-Term Debt | 24.6M -67.14% | 75.0M 0.00% | 75.0M 0.00% | 75.0M +749,900.00% | |
Total Current Liabilities | 122.6M +101.63% | 60.8M -9.38% | 67.1M -18.27% | 82.1M +20.47% | |
Total Long-Term Debt | 49.7M -32.14% | 73.2M +1.16% | 72.4M +1.52% | 71.3M +7,381.11% | |
Total Long-Term Liabilities | 126.2M -8.79% | 138.3M +15.79% | 119.5M +34.62% | 88.7M +327.62% | |
Total Liabilities | 250.2M +23.92% | 201.9M +7.08% | 188.6M -5.95% | 200.5M +48.78% | |
Retained Earnings | -816.2M +16.27% | -702.0M +26.67% | -554.2M +17.87% | -470.2M +38.06% | |
Total Stockholders Equity | -5.8M -108.54% | 67.8M -50.91% | 138.2M +17.36% | 117.7M -36.50% | |
Total Shares Outstanding | 81.1M +3.47% | 78.4M +23.26% | 63.6M +31.20% | 48.5M +8.82% | |
Cash Flow | |||||
Cash from Operating Activities | -46.4M -55.64% | -104.5M -0.83% | -105.4M +44.14% | -73.1M +594.19% | |
Capital Expenditures | 3.8M -22.79% | 5.0M -75.44% | 20.2M -55.13% | 45.0M -2.99% | |
Cash from Investing Activities | -4.1M -117.49% | 23.5M -31.01% | 34.0M +175.69% | -45.0M -27.15% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.3M -77.50% | 54.5M -35.10% | 84.0M -11.74% | 95.2M +5,473.77% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,655.75% +235.55% | -493.44% N/A | N/A N/A | -730.87% +276.47% | |
Return on Assets | -44.42% -10.36% | -49.55% +90.18% | -26.06% -35.83% | -40.61% +74.51% | |
Return on Equity | -368.19% +156.61% | -143.48% +118.50% | -65.67% -23.21% | -85.52% +127.84% | |
Revenue Growth | -80.77% N/A | N/A N/A | N/A N/A | -57.77% -140.61% | |
Current Ratio | 0.75 -63.16% | 2.03 -14.60% | 2.38 +26.54% | 1.88 -30.09% | |
Cash Ratio | 0.54 -68.45% | 1.71 -11.71% | 1.93 +37.24% | 1.41 -30.36% | |
Debt-to-Equity Ratio | -12.83 -687.21% | 2.19 +104.88% | 1.07 -14.16% | 1.24 +23,794.23% | |
Debt-to-Assets Ratio | 0.30 -44.66% | 0.55 +21.81% | 0.45 -1.87% | 0.46 +15,223.33% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow